1222010-84-5

Upstream product

• 59142-68-6 2-bromo-4-fluorobenzaldehyde 
• 110-87-2 3,4-dihydro-2H-pyran 
• 229027-89-8 (2-bromo-4-fluorophenyl)methanol 

Downstream Products

• 1222010-85-6 2-((4-(benzyloxy)-2-bromobenzyl)oxy)tetrahydro-2H-pyran 
• 1222010-47-0 6-benzyloxy-1,3-dihydro-1-hydroxy-2,1-benzoxaborole 
• 1222010-55-0 1,3-dihydro-1-hydroxy-2,1-benzoxaborol-6-yl N-cyclohexylcarbamate 
• 1222010-64-1 6-(2-nitrobenzyloxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole 
• 1222010-58-3 6-(2-fluorobenzyloxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole 
• 1222010-52-7 1,3-dihydro-1-hydroxy-2,2-benzoxaborol-6-yl N-phenylcarbamate 
• 1222010-61-8 6-(4'-fluoro)benzyloxy-1,3-dihydro-1-hydroxy-2,1-benzoxaborole 
• 1268390-40-4 ethyl [2-(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-6-yloxy)]-2-phenylacetate 
• 1268390-25-5 6-cyclohexylmethoxy-1,3-dihydro-1-hydroxy-2,1-benzoxaborole 
• 947163-26-0 6-methoxybenzo[c][1,2]oxaborol-1(3H)-ol 
• 1196473-37-6 6-hydroxyl-1,3-dihydro-1-hydroxy-2,1-benzoxaborole 

Relevant academic research and scientific papers

1 -HYDROXY-BENZOOXABOROLES AS ANTIPARASITIC AGENTS

Provided are compounds useful for controlling endoparasites both in animals and agriculture. Further provided are methods for controlling endoparasite infestations of an animal by administering an effective amount of a compound as described above, or a pharmaceutically acceptable salt thereof, to an animal, as well as formulations for controlling endoparasite infestations using the compounds described above or an acceptable salt thereof, and an acceptable carrier. The claimed compounds are described by the following Markush formula:A typical example for a compound according to above formula is: A typical example for a compound according to above formula is:

BORON-CONTAINING SMALL MOLECULES AS ANTI-PROTOZOAL AGENTS

This invention provides, among other things, novel compounds useful for treating protozoal infections, pharmaceutical compositions containing such compounds, as well as combinations of these compounds with at least one additional therapeutically effective agent.